Search Results - Cathy Eng
- Showing 1 - 14 results of 14
-
1
-
2
Publisher Correction: A randomized pilot study of oncology massage to treat chemotherapy-induced peripheral neuropathy by Gabriel Lopez, Cathy Eng, Michael Overman, David Ramirez, Wenli Liu, Curtiss Beinhorn, Pamela Sumler, Sarah Prinsloo, Yisheng Li, Minxing Chen, Eduardo Bruera, Lorenzo Cohen
Published in Scientific Reports (2023-05-01)Get full text
Article -
3
A randomized pilot study of oncology massage to treat chemotherapy-induced peripheral neuropathy by Gabriel Lopez, Cathy Eng, Michael Overman, David Ramirez, Wenli Liu, Curtiss Beinhorn, Pamela Sumler, Sarah Prinsloo, Yisheng Li, Minxing Chen, Eduardo Bruera, Lorenzo Cohen
Published in Scientific Reports (2022-11-01)Get full text
Article -
4
The association of alternate VEGF ligands with resistance to anti-VEGF therapy in metastatic colorectal cancer. by Christopher H Lieu, Hai Tran, Zhi-Qin Jiang, Muling Mao, Michael J Overman, E Lin, Cathy Eng, Jeffrey Morris, Lee Ellis, John V Heymach, Scott Kopetz
Published in PLoS ONE (2013-01-01)Get full text
Article -
5
Surgical resection and survival outcomes in metastatic young adult colorectal cancer patients by Nina D. Arhin, Chan Shen, Christina E. Bailey, Lea K. Matsuoka, Alexander T. Hawkins, Andreana N. Holowatyj, Kristen K. Ciombor, Michael B. Hopkins, Timothy M. Geiger, Audrey E. Kam, Marc T. Roth, Cody M. Lebeck Lee, Michael Lapelusa, Arvind Dasari, Cathy Eng
Published in Cancer Medicine (2021-07-01)Get full text
Article -
6
Ligand-activated EGFR/MAPK signaling but not PI3K, are key resistance mechanisms to EGFR-therapy in colorectal cancer by Xueping Qu, Habib Hamidi, Radia M. Johnson, Ethan S. Sokol, Eva Lin, Cathy Eng, Tae Won Kim, Johanna Bendell, Smruthy Sivakumar, Benjamin Kaplan, Felipe de Sousa e Melo, Andrew Mancini, Matthew Wongchenko, Yi Shi, David Shames, Yibing Yan, Fortunato Ciardiello, Carlos Bais
Published in Nature Communications (2025-05-01)Get full text
Article -
7
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gastrointestinal cancer by Lipika Goyal, Smitha Krishnamurthi, Dung T Le, Ronan J Kelly, Cathy Eng, Geoffrey Ku, Manish A Shah, Marwan Fakih, Joseph Chao, Van K Morris, Katherine Bever, Kristen K Ciombor, Joleen Hubbard, Renuka Iyer, Holly T Kemberling, Mindy Mintz Mordecai, Andrew Scott Paulson, Valerie Peterson
Published in Journal for ImmunoTherapy of Cancer (2023-06-01)Get full text
Article -
8
Association of SMAD4 mutation with patient demographics, tumor characteristics, and clinical outcomes in colorectal cancer. by Amir Mehrvarz Sarshekeh, Shailesh Advani, Michael J Overman, Ganiraju Manyam, Bryan K Kee, David R Fogelman, Arvind Dasari, Kanwal Raghav, Eduardo Vilar, Shanequa Manuel, Imad Shureiqi, Robert A Wolff, Keyur P Patel, Raja Luthra, Kenna Shaw, Cathy Eng, Dipen M Maru, Mark J Routbort, Funda Meric-Bernstam, Scott Kopetz
Published in PLoS ONE (2017-01-01)Get full text
Article -
9
Treatment of primary rectal adenocarcinoma after prior pelvic radiation: The role of hyperfractionated accelerated reirradiation by Garrett Jensen, MD, Randa Tao, MD, Cathy Eng, MD, John M. Skibber, MD, Miguel Rodriguez-Bigas, MD, George J. Chang, MD, Y. Nancy You, MD, Brian K. Bednarski, MD, Bruce D. Minsky, MD, Eugene Koay, MD, PhD, Cullen Taniguchi, MD, PhD, Sunil Krishnan, MD, Prajnan Das, MD, MS, MPH
Published in Advances in Radiation Oncology (2018-10-01)Get full text
Article -
10
CEA-CD3 bispecific antibody cibisatamab with or without atezolizumab in patients with CEA-positive solid tumours: results of two multi-institutional Phase 1 trials by Neil H. Segal, Ignacio Melero, Victor Moreno, Neeltje Steeghs, Aurelien Marabelle, Kristoffer Rohrberg, Maria E. Rodriguez-Ruiz, Joseph P. Eder, Cathy Eng, Gulam A. Manji, Daniel Waterkamp, Barbara Leutgeb, Said Bouseida, Nick Flinn, Meghna Das Thakur, Markus C. Elze, Hartmut Koeppen, Candice Jamois, Meret Martin-Facklam, Christopher H. Lieu, Emiliano Calvo, Luis Paz-Ares, Josep Tabernero, Guillem Argilés
Published in Nature Communications (2024-05-01)Get full text
Article -
11
Phase II study of durvalumab (anti-PD-L1) and trametinib (MEKi) in microsatellite stable (MSS) metastatic colorectal cancer (mCRC) by Ignacio I Wistuba, Andrew Futreal, Xuemei Wang, Arvind Dasari, Cathy Eng, Scott Kopetz, Edwin R Parra, Cara L Haymaker, Eduardo Vilar, Robert A Wolff, Kanwal Raghav, Michael J Overman, Younghee Lee, Benny Johnson, Luisa Maren Solis Soto, Jane V Thomas, Van K Morris, Bryan K Kee, Christine M Parseghian, Daniele Lorenzini, Caddie Laberiano-Fernandez, Anuj Verma, Wenhua Lang
Published in Journal for ImmunoTherapy of Cancer (2022-08-01)Get full text
Article -
12
Genetic susceptibility markers for a breast-colorectal cancer phenotype: Exploratory results from genome-wide association studies. by Mala Pande, Aron Joon, Abenaa M Brewster, Wei V Chen, John L Hopper, Cathy Eng, Sanjay Shete, Graham Casey, Fredrick Schumacher, Yi Lin, Tabitha A Harrison, Emily White, Habibul Ahsan, Irene L Andrulis, Alice S Whittemore, Esther M John, Aung Ko Win, Enes Makalic, Daniel F Schmidt, Miroslaw K Kapuscinski, Heather M Ochs-Balcom, Steven Gallinger, Mark A Jenkins, Polly A Newcomb, Noralane M Lindor, Ulrike Peters, Christopher I Amos, Patrick M Lynch
Published in PLoS ONE (2018-01-01)Get full text
Article -
13
Preoperative radiation dose escalation for rectal cancer using a concomitant boost strategy improves tumor downstaging without increasing toxicity: A matched-pair analysis by Jillian R. Gunther, MD, PhD, Awalpreet S. Chadha, MD, Ui Sup Shin, MD, In Ja Park, MD, Kiran V. Kattepogu, MD, Jonathan D. Grant, MD, David C. Weksberg, MD, PhD, Cathy Eng, MD, Scott E. Kopetz, MD, PhD, Prajnan Das, MD, MS, MPH, Marc E. Delclos, MD, Harmeet Kaur, MD, Dipen M. Maru, MD, John M. Skibber, MD, Miguel A. Rodriguez-Bigas, MD, Y. Nancy You, MD, Sunil Krishnan, MD, George J. Chang, MD, MS
Published in Advances in Radiation Oncology (2017-07-01)Get full text
Article -
14
International consensus to define outcomes for trials of chemoradiotherapy for anal cancer (CORMAC-2): defining the outcomes from the CORMAC core outcome set by Robert Samuel, Stephen R. Knight, Richard Adams, Prajnan Das, Jennifer Dorth, David Finch, Marianne G. Guren, Maria A. Hawkins, Susan Moug, Lakshmi Rajdev, David Sebag-Montefiore, Andrew G. Renehan, Rebecca Fish, Miguel A. Rodriguez-Bigas, Pratik Adusumilli, Ahmed Allam Mohamed, Mario Alvarez Gallego, Eva Angenete, Ane Appelt, Maaike Berbee, Danielle Brogden, Peter Brown, Lucy Buckley, Nathalie Casanova, Rachel Cooper, Nuno Couto, Peter Coyne, Tamzin Cuming, Charlotte Deijin, Kristopher Dennis, Cathy Eng, Alexandra Gilbert, Duncan Gilbert, Karyn Goodman, Rashmi Jadon, Anders Johnsson, Arunansu Kar, Ethan Ludmir, Marie-Louise Lydrup, Ivan Lyra-Gonzalez, Stefania Manfrida, Rebecca Muirhead, Sarah O'Dwyer, Thomas Rackley, Lukasz Raszewski, Leslie Samuel, Mark Saunders, Andrew Scarsbrook, Eva Segelov, Timothy Simmons, Paul Sutton, Nicholas Symons, Deborah Williamson
Published in EClinicalMedicine (2024-12-01)Get full text
Article
